Default company panoramic image
E7ff18e9 73a3 4a3b 86df 0f531f51f2a7

OTraces, Inc.

Simple Screening Blood Test Assays for Cancers; Breast, Ovarian, Prostate, Colon, Lung, and Melanoma.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Rockville, MD, USA
  • Currency USD
  • Founded April 2008
  • Employees 5
  • Website otraces.com

Company Summary

OTraces has diagnostic detection methods for cancer that have superior predictive power 98% with breast cancer test in clinical labs. We have data for breast, prostate, ovarian and lung all with greater than 95% predictive power. We are in final stage of market validation for the breast cancer detection test at the Gertsen Institute in Moscow for the Russian Ministry of Health. The system is fully automated for the clinical lab and in production.

Team

  • Default avatar
    Keith Lingenfelter
    CEO

  • Default avatar
    Richard Saul Ph.D.
    VP Product Deleopemnt

  • Default avatar
    Alain Cappeluti
    CFO

Advisors

  • Default avatar
    Womble & Carlyle
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    State of Virginia|Former CFO Human Genome Sciences.|Other Angels
    Unconfirmed